
Through increased utilization of multi-omic data, health care professionals can revolutionize the treatment paradigm of countless diseases.
Christian Olsen is the Associate VP, Industry Principal of Biologics at Dotmatics, a leader in R&D scientific software connecting science, data and decision-making.

Through increased utilization of multi-omic data, health care professionals can revolutionize the treatment paradigm of countless diseases.

The importance of findability, accessibility, interoperability, and reusability has become even more significant to academics as government agencies increasingly require data openness and accessibility for funding eligibility.

Precision medicine is rooted in the reality that the way patients respond to treatment is heavily affected by their individual genetic variability, their complex biology, and external factors.

The willingness of biology labs to evolve has been essential to the incredible rise of biologic drugs.

Generic small molecule drugs take advantage of abbreviated approval pathways and have markedly lower development costs compared to their reference products.